The Journal of Allergy and Clinical Immunology
Volume 116, Issue 5 , Pages 976-982 , November 2005

Spirometric criteria for asthma: Adding further evidence to the debate

  • Sarah L. Appleton, BSc (Hons)

      Affiliations

    • From The Health Observatory, Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital Campus, Woodville
    • ,
  • Robert J. Adams, MBBS, MD

      Affiliations

    • From The Health Observatory, Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital Campus, Woodville
    • Corresponding Author InformationReprint requests: Robert J. Adams, MBBS, MD, The Health Observatory, Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital Campus, Woodville Rd, Woodville, South Australia, 5011.
    • ,
  • David H. Wilson, PhD

      Affiliations

    • From The Health Observatory, Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital Campus, Woodville
    • ,
  • Anne W. Taylor, MPH

      Affiliations

    • Population Research and Outcome Studies Unit, South Australian Department of Health, Adelaide
    • ,
  • Richard E. Ruffin, MBBS, MD

      Affiliations

    • From The Health Observatory, Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital Campus, Woodville
    • ,
  • on behalf of the North West Adelaide Cohort Health Study Team

Received 29 March 2005 ,Revised 2 August 2005 ,Accepted 18 August 2005.

References 

  1. Dow L. Asthma in older people. Clin Exp Allergy. 1998;28(suppl 5):195–202
  2. Banerjee DK, Lee GS, Malik SK, Daly S. Underdiagnosis of asthma in the elderly. Br J Dis Chest. 1987;81:23–29
  3. Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest. 1999;1163:603–613
  4. Parameswaran K, Hildreth AJ, Chadha D, Keaney NP, Taylor IK, Bansal SK. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Respir Med. 1998;923:573–577
  5. McIvor RA, Tashkin DP. Underdiagnosis of chronic obstructive pulmonary disease: a rationale for spirometry as a screening tool. Can Respir J. 2001;83:153–158
  6. Peat J, Toelle B, Marks G, Mellis C. Continuing the debate about measuring asthma in population studies. Thorax. 2001;56:406–411
  7. Cockcroft D, Killian D, Mellon J, Hargreave F. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7:235
  8. Palmeiro EM, Hopp RJ, Biven RE, Bewtra AK, Nair NN, Townley RG. Probability of asthma based on methacholine challenge. Chest. 1992;1013:630–633
  9. Joyce DP, Chapman KR, Kesten S. Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms. Chest. 1996;1093:697–701
  10. Van Schayck C. Diagnosis of asthma and chronic obstructive pulmonary disease in general practice. Br J Gen Pract. 1996;46:193–197
  11. Marabini M, Stopponi R, Matteucci G, Pettinari L, Surano E, Marcucci F, et al. Reported diagnosis of previous asthma in a sample of the Italian general population. Monaldi Arch Chest Dis. 2001;564:299–303
  12. Lewis SA, Weiss ST, Britton JR. Airway responsiveness and peak flow variability in the diagnosis of asthma for epidemiological studies. Eur Respir J. 2001;186:921–927
  13. Greenspon L, Morrissey W. Factors that contribute to inhibition of methacholine-induced bronchoconstriction. Am Rev Respir Dis. 1986;133:735–739
  14. Cockcroft DW, Berscheid BA, Murdock KY. Unimodal distribution of bronchial responsiveness to inhaled histamine in a random human population. Chest. 1983;835:751–754
  15. Brand P, Postma D, Kerstjens H, Koeter G. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. The Dutch CNSLD Study Group. Am Rev Respir Dis. 1991;143:916–921
  16. Greenspon LW, Gracely E. A discriminant analysis applied to methacholine bronchoprovocation testing improves classification of patients as normal, asthma, or COPD. Chest. 1992;1025:1419–1425
  17. Sparrow D, O'Connor G, Colton T, Barry C, Weiss S. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function. The Normative Aging Study. Am Rev Respir Dis. 1987;135:1255–1260
  18. Hopp RJ, Bewtra A, Nair NM, Townley RG. The effect of age on methacholine response. J Allergy Clin Immunol. 1985;764:609–613
  19. National Institutes of Health, National Heart Lung and Blood Institute . Guidelines for the diagnosis and management of asthma. Bethesda (MD): National Institutes of Health; 1997;Publication no. 97-4051
  20. Shim C, Williams MJ. Evaluation of the severity of asthma: patients versus physicians. Am J Med. 1980;68:11–13
  21. Russell N, Crichton N, Emerson P, Morgan A. Quantitative assessment of the value of spirometry. Thorax. 1986;41:360–363
  22. Scottish Intercollegiate Guidelines Network , The British Thoracic Society . British guideline on the management of asthma. Thorax. 2003;58(suppl 1):i1–i94
  23. American Thoracic Society . Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis. 1991;144:1202–1218
  24. National Heart Lung and Blood Institute . Global Initiative for Asthma. Bethesda (MD): National Institutes of Health; 2003;Publication no. 02-3659
  25. Calverley P, Burge P, Spencer S, Anderson J, Jones P. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58:659–664
  26. Guyatt G, Townsend M, Nogradi S, Pugsley S, Keller J, Newhouse M. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med. 1988;148:1949–1952
  27. Mendella L, Manfreda J, Warren C, Anthonisen N. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med. 1982;96:17–21
  28. Berger R, Smith D. Acute postbronchodilator changes in pulmonary function parameters in patients with chronic airways obstruction. [published erratum appears in Chest 1988;94:674] Chest. 1988;933:541–546
  29. Anthonisen N, Wright E, Hodgkin J. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989;133:14–20
  30. Brand P, Quanjer P, Postma D, Kerstjens H, Koeter G, Dekhuijzen P, et al. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax. 1992;47:429–436
  31. Reid D, Soltani A, Johns D, Bish R, Williams T, Burns G, et al. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Intern Med J. 2003;33:572–577
  32. Dorinsky P, Reisner C, Ferguson G, Menjoge S, Serby C, Witek TJ. The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD. Chest. 1999;115:966–971
  33. Mahler D, Wire P, Horstman D, Chang C, Yates J, Fischer T, et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:1084–1091
  34. Rossi A, Kristufek P, Levine B, Thomson M, Till D, Kottakis J, et al. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. Chest. 2002;121:1058–1069
  35. Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest. 2003;123:1441–1449
  36. National Institute for Clinical Excellence . Chronic Obstructive Pulmonary Disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59(suppl 1):1–232
  37. Adams RJ, Wilson DH, Appleton S, Taylor A, Dal Grande E, Chittleborough CR, et al. Underdiagnosed asthma in South Australia. Thorax. 2003;5810:846–850
  38. Taylor A, Wilson D, Wakefield M. Differences in health estimates using telephones and door-to-door survey methods—a hypothetical exercise. Aust N Z J Public Health. 1998;22:223–226
  39. American Thoracic Society . Standardization of spirometry 1987 update. Am Rev Respir Dis. 1987;136:1285–1298
  40. Selim A, Ren X, Fincke G, Rogers W, Lee A, Kazis L. A symptom-based measure of the severity of chronic lung disease: results from the Veterans Health Study. Chest. 1997;111:1607–1614
  41. Ruffin R, Wilson D, Chittleborough C, Southcott A, Smith B, Christopher D. Multiple respiratory symptoms predict quality of life in chronic lung disease: a population-based study of Australian adults. Qual Life Res. 2000;9:1031–1039
  42. Hosmer D, Lemeshow S. Applied logistic regression. New York: John Wiley; 1989;
  43. Quanjer P, Tammeling G, Cotes J, Perdersen O, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(suppl 16):5–40
  44. Connolly M, Crowley J, Charan N, Nielson C, Vestal R. Reduced subjective awareness of bronchoconstriction provoked my methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax. 1992;47:410–413
  45. Global Initiative for Chronic Obstructive Pulmonary Disease . Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report. Bethesda (MD): National Heart, Lung, and Blood Institute; 2001;NIH publication no. 2701
  46. Toren K, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest. 1993;1042:600–608
  47. Tweeddale P, Merchant S, Leslie M, Alexander F, McHardy G. Short term variability in FEV1: relation to pretest activity, level of FEV1, and smoking habits. Thorax. 1984;39:928–932
  48. Tweeddale PM, McHardy GJ. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax. 1987;42:487–490
  49. Burge P, Calverley P, Jones P, Spencer S, Anderson J on behalf of the ISOLDE Study Group. Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax. 2003;58:654–658
  50. Lorber D, Kaltenborn W, Burrows B. Responses to isoproterenol in a general population sample. Am Rev Respir Dis. 1978;118:855–861
  51. Dales R, Spitzer W, Tousignant P, Schechter M, Suissa S. Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis. 1988;38:317–320
  52. Australian Bureau of Statistics . 2001 Census basic community profile and snapshot. Canberra (ACT): ABS; 2001;

 Supported by the University of Adelaide and the South Australian Department of Health.

PII: S0091-6749(05)01923-8

doi: 10.1016/j.jaci.2005.08.034

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 5 , Pages 976-982 , November 2005

Article Tools